Cannonau Corp. engages in the development of cannabidiol-based products. The company is headquartered in Skaneateles, New York and currently employs 0 full-time employees. The company went IPO on 2008-02-11. The firm uses nanotechnology plans to offer the advanced CBD for improved bioavailability and benefit.
